These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 6230880)
1. Some functional changes in experimentally induced cardiac overload. Petkov O Acta Physiol Pharmacol Bulg; 1983; 9(3):42-50. PubMed ID: 6230880 [TBL] [Abstract][Full Text] [Related]
2. Changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and M-cholinergic systems in experimental isoprenaline myocardial hypertrophy. Kolarova R; Petkov O; Popova N Acta Physiol Pharmacol Bulg; 1991; 17(2-3):111-7. PubMed ID: 1668133 [TBL] [Abstract][Full Text] [Related]
3. Changes in blood plasma and myocardial lipids in experimental thyrotoxic myocardial hypertrophy in rabbits. Petkov O; Orbetsova V; Dakovska L Cor Vasa; 1985; 27(6):464-72. PubMed ID: 4092475 [TBL] [Abstract][Full Text] [Related]
4. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats]. Prodanov K; Kolarova R; Tsakova L; Balutsov M Eksp Med Morfol; 1991; 30(1):26-30. PubMed ID: 1832104 [TBL] [Abstract][Full Text] [Related]
5. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629 [TBL] [Abstract][Full Text] [Related]
6. Early metabolic alterations during the development of experimentally induced cardiac hypertrophy. Zimmer HG; Gerlach E Arzneimittelforschung; 1980; 30(11a):2001-7. PubMed ID: 6452127 [TBL] [Abstract][Full Text] [Related]
7. Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice. Errami M; Galindo CL; Tassa AT; Dimaio JM; Hill JA; Garner HR J Pharmacol Exp Ther; 2008 Mar; 324(3):1196-203. PubMed ID: 18089841 [TBL] [Abstract][Full Text] [Related]
8. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294 [TBL] [Abstract][Full Text] [Related]
9. [The effect of vitaton on a model of isoprenaline myocardiopathy in rats]. Gendzhev Z; Taskov M; Petrova V Eksp Med Morfol; 1989; 28(4):37-42. PubMed ID: 2627901 [TBL] [Abstract][Full Text] [Related]
10. S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes. Padmanabhan M; Mainzen Prince PS Life Sci; 2007 Feb; 80(10):972-8. PubMed ID: 17182065 [TBL] [Abstract][Full Text] [Related]
11. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats. Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Priscilla DH; Prince PS Chem Biol Interact; 2009 May; 179(2-3):118-24. PubMed ID: 19146839 [TBL] [Abstract][Full Text] [Related]
14. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice. Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036 [TBL] [Abstract][Full Text] [Related]
15. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Zordoky BN; Aboutabl ME; El-Kadi AO Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis. Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160 [TBL] [Abstract][Full Text] [Related]
17. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528 [TBL] [Abstract][Full Text] [Related]
18. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of isoprenaline pretreatment on the cardiotoxic effect of the same drug. Faltová E; Mráz M; Sedivý J Physiol Bohemoslov; 1983; 32(4):307-17. PubMed ID: 6622555 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Li L; Zhang LK; Pang YZ; Pan CS; Qi YF; Chen L; Wang X; Tang CS; Zhang J Acta Pharmacol Sin; 2006 May; 27(5):527-35. PubMed ID: 16626506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]